NAVINFLUOR2023-04-012023-06-30 NAVINFLUOR2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member NAVINFLUOR2023-06-30 NAVINFLUOR2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532504 NAVINFLUOR NOTLISTED Navin Fluorine International Limited Equity 2023-04-01 2024-03-31 2023-07-31 2023-07-17 INR Crores First quarter 12:35:00 14:10:00 2023-07-31 2023-07-31 Not applicable Single segment Chemicals 2023-04-01 2023-06-30 Unaudited Standalone 3507100000.00 115800000.00 3622900000.00 1609800000.00 0.00 -155500000.00 586900000.00 16000000.00 115900000.00 620500000.00 2793600000.00 829300000.00 0.00 829300000.00 197400000.00 1800000.00 199200000.00 0.00 630100000.00 0.00 0.00 0.00 0.00 630100000.00 -13200000.00 616900000.00 616900000.00 0.00 99100000.00 2 12.71 12.67 0.00 0.00 12.71 12.67 1.The results of the quarter ended 30th June, 2023 were reviewed by the Audit Committee and approved by the Board of Directors of the Company, at its meeting held on 31st July, 2023. They have been subjected to limited review by the statutory auditors. 2. During the year ended 31st March, 2023, the Board approved the grant of 1,55,000 stock options at par under Employee Stock Option Scheme 2017, to the senior leadership of the Company. The charge on account of aforementioned ESOP for the quarter ended 30th June, 2023 and 31st March, 2023 and year ended 31st March, 2023 was Rs. 5.38 crores, Rs. 9.31 crores and Rs. 16.79 crores respectively 3. During the quarter ended March 31, 2023, the Company completed an exercise to revise the estimated useful life of assets at Dewas (namely Plant & Machinery and Buildings) with the help of an external technical consultants. Consequently, the depreciation charge for the quarter and year ended 31st March 2023 was lower by Rs.5.30 crores. 4. The figures for the quarter ended 31st March, 2023 are balancing figures between the audited figures in respect of the full financial year and the published year to date figures for the nine months period ended 31st December 2022. 5. The Company has identified Chemicals business as its only primary reportable segment in accordance with the requirements of Ind AS 108, ‘Operating Segments'. Accordingly, no separate segment information has been provided. Other Expenses 620500000.00 Remeasurement loss of the defined benefit obligation -17600000.00 -17600000.00 -4400000.00 0.00